Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/130727
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGarcía Rizo, Clemente-
dc.contributor.authorKirkpatrick, Brian-
dc.contributor.authorFernández-Egea, Emilio-
dc.contributor.authorOliveira, Cristina-
dc.contributor.authorBernardo Arroyo, Miquel-
dc.date.accessioned2019-03-21T18:00:29Z-
dc.date.available2019-03-21T18:00:29Z-
dc.date.issued2016-05-01-
dc.identifier.issn0306-4530-
dc.identifier.urihttp://hdl.handle.net/2445/130727-
dc.description.abstractObjective: Patients with serious mental illnesses exhibit a reduced lifespan compared with the general population, a finding that can not solely rely on high suicide risk, low access to medical care and unhealthy lifestyle. The main causes of death are medical related pathologies such as type 2 diabetes mellitus and cardiovascular disease; however pharmacological treatment might play a role. Material and methods: We compared a two hour glucose load in naïve patients at the onset of a serious mental illness (N = 102) (84 patients with a first episode of schizophrenia and related disorders, 6 with a first episode of bipolar I disorder and 12 with a first episode of major depression disorder) with another psychiatric diagnose, adjustment disorder (N = 17) and matched controls (N = 98). Results: Young patients with serious mental illness showed an increased two hour glucose load compared with adjustment disorder and the control group. Mean two hour glucose values [±standard deviation] were: for schizophrenia and related disorders 106.51 mg/dL [±32.0], for bipolar disorder 118.33 mg/dL [±34.3], for major depressive disorder 107.42 mg/dL [±34.5], for adjustment disorder 79.06 mg/dL[±24.4] and for the control group 82.11 mg/dL [±23.3] (p < 0.001). Conclusions: Our results reflect an abnormal metabolic pathway at the onset of the disease before any pharmacological treatment or other confounding factors might have taken place. Our results suggest a similar glycemic pathway in serious mental illnesses and the subsequent need of primary and secondary prevention strategies.-
dc.format.extent14 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherElsevier Ltd-
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1016/j.psyneuen.2016.02.001-
dc.relation.ispartofPsychoneuroendocrinology, 2016, vol. 67, p. 70-75-
dc.relation.urihttps://doi.org/10.1016/j.psyneuen.2016.02.001-
dc.rightscc-by-nc-nd (c) Elsevier Ltd, 2016-
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es-
dc.sourceArticles publicats en revistes (Medicina)-
dc.subject.classificationTrastorn bipolar-
dc.subject.classificationEsquizofrènia-
dc.subject.classificationDepressió psíquica-
dc.subject.classificationMortalitat-
dc.subject.otherManic-depressive illness-
dc.subject.otherSchizophrenia-
dc.subject.otherMental depression-
dc.subject.otherMortality-
dc.titleAbnormal glycemic homeostasis at the onset of serious mental illnesses: A common pathway-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.identifier.idgrec665724-
dc.date.updated2019-03-21T18:00:29Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid26878465-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
665724.pdf288.67 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons